Should I buy MarketAxess (MKTX) stock or is it too late?

MarketAxess · Financials · price $162

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Keefe, Bruyette & Woods — 67% of its targets hit on this sector (291 calls tested). It aims for $167 (+2.8 %), call made on August 12, 2026, maturing on August 12, 2027 (16 d ago).

The 3 reliable analysts $167+2.8 %

The 5 other firms $134-17 %

How to read it: the 3 reliable firms are not filtered by optimism — 2 aim above the price, 1 below, hence their $167 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on MarketAxess

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Barclays	50 %	+13.8 %	6	$167 +3%
Rosenblatt	40 %	-6.4 %	25	$210 +29%
UBS	33 %	-8.4 %	6	$167 +3%
Citigroup	38 %	-8.7 %	8	$265 +63%
Raymond James	45 %	+6.2 %	11	—

In short — Should you invest in MarketAxess? Is it too late, still worth it? Analysts are split (0% buy, median target $151, i.e. -7%), and the most reliable on MKTX targets even higher. But it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

The most reliable firm on MKTX, Keefe, Bruyette & Woods (100% hit rate, 4 scored calls), targets $167 (call made on August 11, 2026, maturing on August 11, 2027) (+3%) in its most recent call, and $198 (call made on November 10, 2025, maturing on November 10, 2026) (+22%) in the one coming due soonest.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 9 ratings, 9 are neutral.
Limited upside: the median target is only -7% from the current price.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
No dividend: your return depends only on price appreciation.

The analyst consensus on MKTX

Median target $151 (-7%) · 9 ratings · Hold consensus

Strong Buy00%

Buy00%

Hold9100%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in MarketAxess now?

We won't decide for you. The facts: 0% of analysts rate it a buy, median target $151 (-7%), and Keefe, Bruyette & Woods (most reliable on MKTX, 100%) targets $167. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in MarketAxess?

The stated upside is small: the median target ($151) sits just -7% from the price ($162) (most reliable on MKTX: Keefe, Bruyette & Woods, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is MarketAxess still worth investing in?

It depends on the gap between the price ($162) and its estimated value: analysts target $151 on median (-7%), with 0% buys (most reliable on MKTX: Keefe, Bruyette & Woods, 100%). Cross-check with their real reliability on MKTX and the cautions above. Information, not advice.

What's the main risk in buying MKTX?

The consensus is not unanimous: of 9 ratings, 9 are neutral.

→ Go deeper: the full MarketAxess profile (consensus, analyst reliability, price target, performance).